Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands
Graphical abstract
A novel class of phenylpyrazole fused Wieland–Miescher ketone derivatives are high affinity, receptor specific, selective modulators of glucocorticoid receptor (GR) function.
Section snippets
Acknowledgements
We are grateful to I. Rogatsky, B. Darimont, and H. Luecke for plasmids. Research support was from the National Institutes of Health (DK 57574).
References and notes (33)
Clin. Dermatol.
(1986)- et al.
Pulm. Pharmacol. Ther.
(2002) - et al.
FEBS Lett.
(1999) - et al.
J. Biol. Chem.
(1997) - et al.
J. Biol. Chem.
(1997) - et al.
Tetrahedron Lett.
(2000) - et al.
J. Biol. Chem.
(1998) - et al.
J. Biol. Chem.
(1999) - et al.
Nature
(1998) - et al.
Mol. Biol. (Mosk)
(1997)
EMBO J.
J. Am. Chem. Soc.
Genes Dev.
J. Virol.
Cited by (80)
Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor
2020, Pharmacological ResearchCitation Excerpt :A great deal of enzymes, such as phosphoenolpyruvate carboxy kinase (PEPCK) involved in gluconeogenesis and tyrosine aminotransferase (TAT) of protein catabolism, are regulated by the GREs and may conduce to some of the GCs metabolic action [34,39]. There are three distinct types of GREs, namely simple, composite, and tethering [40]. Genes transcription activation stimulated by GR through simple and composite GREs are relied on the combination of the activated GR homodimer and DNA directly [41].
Manipulating the Brain Corticosteroid Receptor Balance: Focus on Ligands and Modulators
2017, Stress: Neuroendocrinology and NeurobiologyCoregulator cell cycle and apoptosis regulator 1 (CCAR1) positively regulates adipocyte differentiation through the glucocorticoid signaling pathway
2014, Journal of Biological ChemistryCitation Excerpt :Nevertheless, glucocorticoids are also infamous for adverse metabolic side effects associated with the chronic administration required to treat these diseases effectively. For approximately two decades, great efforts have been made to identify and develop for clinical use selective GR ligands that dissociate beneficial anti-inflammatory effects from adverse metabolic effects of glucocorticoids (8–11), but unfortunately with little success. Another possible approach to this problem may be offered by coregulators, which have been shown to function in a gene-specific manner with GR and other transcription factors and, therefore, may represent potential targets for combination therapy to accompany the use of classical anti-inflammatory steroids such as dex.
The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation
2014, Bioorganic and Medicinal Chemistry LettersHeterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3- phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core
2013, Bioorganic and Medicinal Chemistry LettersSynthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists
2013, Bioorganic and Medicinal Chemistry Letters